Discover 921 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 921
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
for
Parkinsons Disease (PD)
Location: Portland OR, Kirkland WA, Vancouver, Palo Alto CA,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 45 - 70+
Code: NCT06944522
Phase3, Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Portland OR, Santa Monica CA, Denver CO, Phoenix AZ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03972657
Phase1, Phase2, Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
for
Neuroblastoma
Location: Portland OR, Oakland CA, San Diego CA, Minneapolis MN,
Sponsor: Giselle Sholler
Sex: All
Age: 1 - 21
Code: NCT05489887
Phase2, Recruiting
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
for
Neuroblastoma
Location: Portland OR, Dallas TX, Austin TX, St Louis MO,
Sponsor: Giselle Sholler
Sex: All
Age: 1 - 21
Code: NCT06540963
Phase2, Recruiting
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
for
Medulloblastoma
Location: Portland OR, Sacramento CA, Oakland CA, Stanford CA,
Sponsor: Giselle Sholler
Sex: All
Age: 0 - 21
Code: NCT04696029
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
for
Congenital Diaphragmatic Hernia
Location: Portland OR, Seattle WA, Palo Alto CA,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0
Code: NCT05213676
Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Portland OR, Seattle WA, Boise ID, San Francisco CA,
Sponsor: Edwards Lifesciences
Sex: All
Age: 65+
Code: NCT04889872
Recruiting
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
for
Juvenile Psoriatic Arthritis
Location: Portland OR, Salt Lake City UT, Loma Linda CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 17
Code: NCT06751238
Phase1, Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
for
Systemic Lupus Erythematosus
Location: Portland OR, Vancouver, Salt Lake City UT,